All Roll Calls
Yes: 101 • No: 1
Sponsored By: Ryan D. Wilcox (Republican)
Signed by Governor
Personalized for You
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Beginning May 6, 2026, staff employed by licensed Utah emergency medical services agencies may distribute, dispense, or administer controlled drugs. This authority covers Schedule II–V drugs within the agency's license and state and federal law. Staff must follow a written standing order or verbal order from the agency's medical director. Another authorized medical professional may also give a verbal order. These orders allow emergency treatment without the ordering professional being physically present.
Beginning May 6, 2026, federally registered Utah emergency medical services agencies need a state license for each registered location. Each agency must maintain at least one registered location, but separate federal registration is not required for every station. Licenses renew every two years; the Division of Professional Licensing may shift renewal periods by up to one year to stagger renewals. The Division may charge reasonable fees covering license costs; amounts are not specified. After consulting the Bureau of Emergency Medical Services, it may set storage, hospital restocking, and recordkeeping rules. Agencies must keep required drug records and inventories, allow authorized inspections, and avoid unauthorized distributions or false information.
Beginning May 6, 2026, Utah may deny, suspend, revoke, or place emergency agencies' controlled drug licenses on probation. Grounds include false application information, drug-law violations, certain prior licensing actions, refusal of inspections, and conduct threatening public safety. Discipline may cover specific drugs, and imminent public danger allows immediate suspension during proceedings. Federal Drug Enforcement Administration registration denial, surrender, suspension, or revocation requires immediate state suspension; reinstatement generally requires restored federal registration. The Division may seal drugs after suspension, generally keeping them sealed through appeals, subject to court-ordered exceptions. It must promptly notify federal drug officials of license suspensions, revocations, and drug forfeitures. Specified violations carry civil penalties up to $5,000; unpaid penalties may go to collections or court, with attorney fees and costs awarded after successful court collection. Penalty receipts go into the General Fund as dedicated funding for controlled drug database equipment, staff training, and outside grants or matching funds.
Ryan D. Wilcox
Republican • House
Evan J. Vickers
Republican • Senate
All Roll Calls
Yes: 101 • No: 1
Senate vote • 3/4/2026
Senate/ passed 2nd & 3rd readings/ suspension
Yes: 23 • No: 0
Senate vote • 3/2/2026
Senate Comm - Favorable Recommendation
Yes: 4 • No: 0
House vote • 2/24/2026
House/ passed 3rd reading
Yes: 66 • No: 1
House vote • 2/19/2026
House Comm - Favorable Recommendation
Yes: 8 • No: 0
Governor Signed
House/ to Governor
House/ received enrolled bill from Printing
House/ enrolled bill to Printing
Enrolled Bill Returned to House or Senate
Draft of Enrolled Bill Prepared
Bill Received from House for Enrolling
House/ signed by Speaker/ sent for enrolling
House/ received from Senate
Senate/ to House
Senate/ signed by President/ returned to House
Senate/ passed 2nd & 3rd readings/ suspension
Senate/ 2nd & 3rd readings/ suspension
Senate/ placed on 2nd Reading Calendar
Senate/ committee report favorable
Senate Comm - Favorable Recommendation
Senate/ to standing committee
Senate/ 1st reading (Introduced)
Senate/ received from House
House/ to Senate
House/ passed 3rd reading
House/ 3rd reading
House/ 2nd reading
House/ committee report favorable
House Comm - Favorable Recommendation
Enrolled
3/7/2026
Substitute #1
2/3/2026
Introduced
1/27/2026